Clarity Pack Section · Medication decisions

For medication decisions that need more than a quick check.

Medication Decisions
Clarity Pack
Section

A deeper WardWise workbook section for significant medication decisions: starting, stopping, changing, continuing, reviewing, reconciling after hospital, checking risk, involving pharmacists, supporting capacity, and recording who owns the next step.

Workbook depth

Autosave enabled

Print / download

Not prescribing advice

Section 1

Decision snapshot

Start by naming the decision clearly. This is where vague medication uncertainty becomes a specific decision that can be discussed, recorded, and reviewed.

Section 2

Current medication picture

Medication decisions are safer when the full medication picture is visible, not just the new tablet or latest change.

Medication list prompt

Keep an up-to-date list with medicine name, dose, reason, start date, intended stop/review date, allergies, side effects noticed, and who owns the next review.

Section 3

Medicine purpose and review table

Use this when there is more than one medicine or when the medication list has become unclear. The aim is to connect each medicine to its reason, duration, review date, and review owner.

Medicine What it is for Temporary, trial, or long-term? Review date / trigger Who owns review?

Purpose table check

If no one can say what a medicine is for, whether it is temporary or long-term, or who owns review, that medicine needs clarification before it disappears into routine.

Section 14

Reason and expected benefit

A clear benefit statement helps prevent medication becoming vague compliance.

Section 4

What matters most to the person?

Medication decisions are not only technical. The right decision may depend on what the person values most: symptom relief, alertness, independence, sleep, comfort, longevity, avoiding falls, avoiding hospital, or avoiding particular side effects.

Values prompt

A medication can be clinically reasonable and still need to fit the person’s life, tolerance, responsibilities, risks, and priorities. This section helps make that visible before the decision becomes automatic.

Section 15

Risks, side effects, burden, and personal relevance

Risk includes more than rare serious harm. It includes what the person has to live with, watch for, manage, or recover from.

Urgent reaction boundary

Severe breathing difficulty, facial or throat swelling, collapse, severe bleeding, severe confusion, suicidal thoughts, sudden major deterioration, or another frightening reaction needs urgent help. Do not try to manage severe reactions alone.

Section 5

Interactions and pharmacy check

The pharmacist is not just handing over the medicine. Pharmacy review can prevent practical medication problems.

Section 6

Alternatives, waiting, and doing nothing

Asking about alternatives is not refusing. It clarifies why this medicine, why now, and what happens if a different route is chosen.

Section 7

Review plan and ownership

A medication without a review plan can become a long-term assumption. Review keeps the decision alive.

Review is not criticism

Reviewing a medicine does not mean it was wrong to start it. It means the decision is being kept alive as the person’s condition, risks, goals, and circumstances change.

Section 8

After hospital: medication reconciliation

After discharge or transfer of care, compare the old list with the new list before medicines are mixed.

Medication Before hospital / before change Now Started / stopped / changed? Who reviews?
Section 9

Communication and handover

Medication problems often happen because one person or team changes something and another person does not know. Use this to check who has been told and who still needs the plan.

Section 13

Stopping, reducing, or deprescribing safely

Stopping medication is also a medication decision. Some medicines can cause harm if stopped suddenly.

Safety boundary

Do not stop, reduce, restart, combine, or change medication based only on this pack section. Use it to speak with the relevant professional so changes are made safely.

Section 10

Capacity, supporter role, and practical understanding

Medication consent can be fragile when someone is confused, overwhelmed, distressed, sedated, exhausted, or not acting like themselves.

Section 11

Questions to ask

Use this section to prepare for GP, hospital, consultant, pharmacist, care home, or mental health medication conversations.

Core medication questions

What is this for? What benefit is expected? What risks matter? What are the alternatives? What happens if we wait? Is this temporary, a trial, or long-term? Who owns review? What should prompt urgent help?

Section 12

Decision record and repeat-back

A medication decision is easier to carry when the final decision and follow-up ownership are written down.

Medication repeat-back

“What I understand is that this medicine is for [reason]. The expected benefit is [benefit]. The main risks or side effects are [risks]. I should take it [how]. It will be reviewed [when]. I should contact [who] if [problem]. Is that correct?”